In particular, HLp-nF1 is nonviable heat-killed microorganism, which exhibits a low risk of sepsis or bacteremia associated with probiotics [32–37], particularly in critically ill or vulnerable patients and pediatric populations, demonstrating comparable effects to those of viable probiotics [26, 36, 38–40]. The gene discussed is NF1; the disease is bacterial infectious disease with sepsis.